[1] |
Zhao L, Chen Z, Zhao Q, et al. Developmental toxicity and genotoxicity studies of wogonin[J]. Regul Toxicol Pharmacol, 2011, 60(2): 212-217. |
[2] |
Liu Y, Wang X, Wang Y, et al. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells[J]. Int J Oncol, 2015,46(1):299-307. |
[3] |
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors[J]. Adv Enzyme Regul, 1984, 22: 27-55. |
[4] |
Zhao Q, Wang J, Zou MJ, et al. Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism[J]. Toxicol Lett,2010, 197(3): 201-210. |
[5] |
Li CJ, Chu CY, Huang LH, et al. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo[J]. Cancer Lett, 2012, 319(2): 203-213. |
[6] |
Lee YM, Cheng PY, Chen SY, et al. Wogonin suppresses arrhythmias, inflammatory responses, and apoptosis induced by myocardial ischemia/reperfusion in rats[J]. J Cardiovasc Pharmacol, 2011, 58(2): 133-142. |
[7] |
Tsai CF, Yeh WL, Huang SM, et al. Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells[J]. Int J Mol Sci, 2012, 13(8): 9877-9892. |
[8] |
Huang KF, Zhang GD, Huang YQ, et al. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway[J]. Int Immunopharmacol, 2012, 12(2): 334-341. |
[9] |
Zhou M, Song X, Huang Y, et al. Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-kappaB signaling pathway[J]. Vasc Pharmacol, 2014, 60(3): 110-119. |
[10] |
Zhao K, Song X, Huang Y, et al. Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-kappaB signaling[J]. Eur J Pharmacol, 2014, 737: 57-69. |